Vimarsana
Biggest News Aggregation in the World

Abuse Liability News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abuse Liability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abuse Liability Today - Breaking & Trending Today

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference - Vimarsana News

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference - Vimarsana News

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

Wellbeing Digital Sciences Inc. , an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... | June 20, 2023

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference - Vimarsana News

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference - Vimarsana News

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--

Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD - Vimarsana News

Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD

– Study did not meet primary endpoint of significant reduction in Emax Drug Liking for ADAIR vs reference dextroamphetamine, although a trend in favor of ADAIR was observed –... | March 21, 2022